Inactive and active states of the interferon-inducible resistance GTPase, Irga6, in vivo.
Irga6, a myristoylated, interferon-inducible member of the immunity-related GTPase family, contributes to disease resistance against Toxoplasma gondii in mice. Accumulation of Irga6 on the T. gondii parasitophorous vacuole membrane is associated with vesiculation and ultimately disruption of the vacuolar membrane in a process that requires an intact GTP-binding domain. The role of the GTP-binding domain of Irga6 in pathogen resistance is, however, unclear. We provide evidence that Irga6 in interferon-induced, uninfected cells is predominantly in a GDP-bound state that is maintained by other interferon-induced proteins. However, Irga6 that accumulates on the parasitophorous vacuole membrane after Toxoplasma infection is in the GTP-bound form. We demonstrate that a monoclonal antibody, 10D7, specifically detects GTP-bound Irga6, and we show that the formation of the 10D7 epitope follows from a GTP-dependent conformational transition of the N terminus of Irga6, anticipating an important role of the myristoyl group on Irga6 function in vivo.
Papic
Natasa
N
Department of Cell Genetics, Institute for Genetics, University of Cologne, 50674 Cologne, Germany.
Hunn
Julia P
JP
Pawlowski
Nikolaus
N
Zerrahn
Jens
J
Howard
Jonathan C
JC
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D002460:Cell Line; D004789:Enzyme Activation; D000939:Epitopes / Q000276:immunology; D020558:GTP Phosphohydrolases / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D006160:Guanosine Triphosphate / Q000378:metabolism; D007371:Interferon-gamma / Q000494:pharmacology*; D051379:Mice; D008958:Models, Molecular; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D014122:Toxoplasma / Q000187:drug effects / Q000201:enzymology / Q000235:genetics
D000911:Antibodies, Monoclonal; D000939:Epitopes; D007371:Interferon-gamma; D006160:Guanosine Triphosphate; D020558:GTP Phosphohydrolases
J Immunol. 1998 Dec 15;161(12):6715-23
9862701
J Biol Chem. 2002 Jun 28;277(26):23515-24
11971904
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):751-5
10639151
Biochemistry. 1997 Apr 15;36(15):4675-84
9109679
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14092-7
16959883
Annu Rev Immunol. 1985;3:501-35
2415142
PLoS Pathog. 2005 Nov;1(3):e24
16304607
J Immunol. 2004 Jan 15;172(2):1163-8
14707092
EMBO J. 2008 Oct 8;27(19):2495-509
18772884
J Biol Chem. 1995 Nov 3;270(44):26707-14
7592898
Genome Biol. 2005;6(11):R92
16277747
J Exp Med. 2001 Jul 16;194(2):181-8
11457893
J Immunol. 2005 Dec 15;175(12):8165-72
16339555
Science. 2003 Oct 24;302(5645):654-9
14576437
J Biol Chem. 1997 Apr 18;272(16):10639-45
9099712
J Immunol. 2007 Aug 1;179(3):1814-24
17641048
Cell. 1998 Oct 16;95(2):237-48
9790530
EMBO J. 1986 Feb;5(2):409-13
2423325
Biochim Biophys Acta. 1963 May 14;71:377-91
18421828
J Immunol. 1969 Nov;103(5):1132-42
4900519
J Immunol. 2008 May 1;180(9):6237-45
18424746
Mol Cell. 2004 Sep 10;15(5):727-39
15350217
Annu Rev Cell Dev Biol. 2007;23:579-611
17506703
J Immunol. 2004 Aug 15;173(4):2594-606
15294976
Infect Immun. 2001 Sep;69(9):5573-6
11500431
J Biol Chem. 2003 Aug 1;278(31):29336-43
12732635
Infect Immun. 2005 Jun;73(6):3278-86
15908352
Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10658-63
16020528
J Exp Med. 2006 Sep 4;203(9):2063-71
16940170
Immunity. 2005 Feb;22(2):163-73
15723805
Nature. 1995 Mar 9;374(6518):190-2
7877694
FEBS Lett. 1979 Nov 1;107(1):198-202
499541